Delivery Order SPE2DB20D2001-SPE2DB22FM35L

Award Date 1/3/22
Potential Completion Date 1/4/22
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Amlodipine-Benazepril 5-10 mg tablets. The $2,433.68 delivery order was placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $1,313.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Amlodipine-Benazepril 5-20 mg pharmaceutical products, with a completion date of July 27, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly within military...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,453.59, is a delivery order for the supply of pharmaceutical products, specifically AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a medication used to treat cardiovascular conditions. The contract is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora,...
This federal contract award is for the delivery of Amlodipine-Benazepril 2.5-10 100S tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,194.36 and was awarded as a delivery order on August 23, 2021, with a completion date of August 24, 2021. The contract is Firm Fixed Price and was not designated with a...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Amlodipine-Benazepril 10-20 mg medication in 100-count bottles. The contract has a ceiling value of $1,358.97 and a completion date of November 13, 2024. It is a firm-fixed-price contract and was not set aside for any specific business category. The award is likely part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,393.08 firm fixed-price delivery order covers the supply of AMLODIPINE-BENAZEPRIL 10-40 MG 100S, a cardiovascular medication, with a period of performance through September 2024. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
The federal contract award, valued at $59,382.11, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order to provide the pharmaceutical product Lotrel 10-20 mg capsules, a medication used for cardiovascular health. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,412.80, is for the delivery of the pharmaceutical product Amlod-Valsa-Hctz 10-160-25 mg, which is used for cardiovascular health and blood pressure management. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
This federal contract award is a Delivery Order (DO) with a Firm Fixed Price (FFP) contract type, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,050.30, is for the delivery of Amlodipine-Benazepril 5-40 mg capsules in 100-count bottles. The award has a completion date of November 13, 2024. This contract is a Child under a larger Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,513.75 firm fixed-price delivery order is for the supply of Amlodipine-Benazepril 10-40 mg capsules, a cardiovascular medication. The contract has an ultimate completion date of January 19, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB22FM35L
    Delivery Order

This federal contract award, valued at $1,111.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Amlodipine-Benazepril 5-10 mg medication, a cardiovascular drug used to treat high blood pressure.

The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:14 PM